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In this work, the inﬂuence of the nature of two materials, with the same chemical com-
position, on their in vitro behavior has been studied. Two routes were used to obtain these
materials with the composition 45% CaO, 22% SiO2, 28% P2O5 and 5% MgO (wt.%). The ﬁrst
material is a glass-ceramic obtained by melting and quenching on cold water and the sec-
ond  one is a ceramic obtained by conventional solid state sintering. In both cases, the raw
materials used were tricalcium phosphate, talc and wollastonite.
The reactivity in simulated body ﬂuid and Tris–HCl solutions was studied. Both materials
showed bioactive behavior, but the glass-ceramic dissolved faster, releasing large proportion
of  Ca and P ions, which afterwards nucleated and precipitated. However, the ceramic was
more  stable under the same conditions in these solutions. Glass-ceramic composite has a
more open structure and allowed the faster formation of a bone-like apatite layer than the
ceramic.
©  2015 SECV. Published by Elsevier España, S.L.U. This is an open access article under the
CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Diferencias  en  el  comportamiento  in  vitro  entre  2  biomateriales  basados
en  Ca3(PO4)2, un  vitrocerámico  y  una  cerámica,  con  la  misma
composición  química
alabras clave:
r  e  s  u  m  e  n
En este trabajo se estudia la inﬂuencia de la naturaleza de 2 materiales con la misma com-
uero ﬁsiológico simulado
ris-HCl
osfato tricálcico
posición química en su comportamiento in vitro. Se han empleado 2 métodos para obtener
estos  materiales con una composición del 45% de CaO, 22% de SiO2, 28% de P2O5 y 5% de MgO
en  peso. El primer material, un vitrocerámico, se obtuvo mediante fusión y colado sobre agua
ollastonita
iocerámicas
fría. El segundo, una cerámica, se consiguió mediante sinterización convencional en estado
sólido. En ambos casos las materias primas fueron fosfato tricálcico, talco y wollastonita.
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Se estudió la reactividad frente a suero ﬁsiológico simulado y solución Tris-HCl. Ambos
materiales han mostrado comportamiento bioactivo pero el vitrocerámico evidencia una
reactividad más alta, liberando cantidades mayores de iones Ca y P, los que poste-
riormente nuclean y precipitan. La muestra cerámica tiene un comportamiento más
estable bajo las mismas condiciones en estas soluciones. El material vitrocerámico tiene
una  estructura más abierta y conduce a la formación más rápida de una capa de
hidroxiapatita.
©  2015 SECV. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access bajo
la  licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The materials, which are used to replace or supplement the
functions of living tissues, are known as biomaterials. Ceram-
ics, glasses and glass-ceramics have succeeded for several
decades for bone repairing applications [1–4]. They are capable
to bond tightly to bone but they are not fully replaced by new
bone. The ﬁrst bioactive biomaterial was developed by Hench
et al. in 1969 [5]. It consists of a silicate glass incorporating
sodium, calcium and phosphorous ions, known as Bioglass®.
In their studies, Hench et al. [6] showed that Bioglass® forms
a calcium phosphate layer on its surface and through that
layer joins to living bone. They found that the calcium phos-
phate layer on the glass can be formed in solutions buffered
to pH 7.4 Tris (hydroxymethyl) aminomethane and hydrochlo-
ric acid (Tris–HCl buffer solution). Hench et al. [7] showed that
some glass was adhered to living bone spontaneously, without
formation of ﬁbrous tissue at the surface. They found that in
glasses of calcium phosphates, a layer can be formed in vitro
in buffered solutions. Since then, it has been found that vari-
ous ceramic materials, such as hydroxyapatite, -tricalcium
phosphate sintered, apatite-wollastonite glass-ceramic [8],
join to living bone.
In the ﬁrst years of study of biomaterials, bioactivity was
determined by in vivo animal tests. In 2006, Kokubo et al. [9]
showed that the in vivo bone bioactivity of a material can be
predicted from the apatite formation onto surface in simu-
lated body ﬂuid solution (SBF which is close to human plasma).
Thus, when new materials are obtained, bioactivity is checked
through in vitro, prior to use in vivo.
The bioactive behavior of glasses and ceramic is identiﬁed
as their ability to react chemically with living tissues, forming
with them mechanically strong bonds. These bone bondings
are attributed to the formation of an apatite-like layer on the
glass surface, with composition and structure equivalent to
the mineral phase of bone.
A lot of different materials have been developed and, in
order to evaluate their goodness, compared with Bioglass®
[6,7,9–11].
Material biodegradation does not depend exclusively on
its physical and chemical properties but also on biological
mechanisms. However, dissolution rate signiﬁcantly affects
the behavior of the material in vivo. If the material has an
appropriate degree of solubility, resorption will take place, i.e.,cells interact with the material and leading the process of bone
regeneration.
The purpose of this paper is to explore the inﬂuence of
the material structure (fully crystalline or glass-ceramic) on
the bioactive behavior. For this, two materials were prepared
with the same chemical composition within SiO2-P2O5-CaO-
MgO quaternary system. In vitro studies were evaluated on two
kinds of solutions, simulated body ﬂuid (SBF) and Tris–HCl pH
7.4. The specimens were characterized by X-Ray Diffraction
(XRD) and Scanning Electron Microscopy (SEM). The solutions
were examined for changes in the concentration of Ca, Mg,  Si
and P ions using Inductively Coupled Plasma Atomic Emission
Spectroscopy (ICP-AES).
Experimental
In the present work, a glass-ceramic (G-TCP60) and a
ceramic (C-TCP60) with the same chemical composition, cor-
responding to 61 wt.% Ca3(PO4)2 (Tricalcium Phosphate: TCP
in short), 24 wt.% CaSiO3 (Wollastonite: W in short) and
15 wt.% 3MgO·4SiO2 (Talc: T in short), were selected in the
Ca3(PO4)2–CaSiO3–3MgO·4SiO2 (TCP-W-T) pseudo-ternary sys-
tem.
The starting materials were a high-purity synthetic
precursor of Ca3(PO4)2 from Carlo Erba Reagents, a reagent-
grade high-purity Hydrous magnesium silicate, Talc, 3MgO
4SiO2·H2O, from Sigma–Aldrich, and a high-purity natural
Wollastonite, CaSiO3, NYAD® 1250 from NYCO®.
Glass-ceramic powders were obtained by melting stoichio-
metric mixtures of the raw materials. The powder mixture
was melted in an electric furnace for 2 h in a Pt crucible at
1500 ◦C. The molten glass was poured in water to obtain a frit
(G-TCP60). Volumetric specimens of the glass-ceramics were
selected for SBF studies and powder samples were used to test
the biodegradability in Tris–HCl.
Polycrystalline bioceramic powder samples were obtained
by conventional solid state sintering route. Raw materials
were mixed by attrition milling in ethanol for 1 h and the
powder was sieved to obtain a powder smaller than 100 m.
Disks of 10 mm in diameter and 5 mm in height were uniaxial
pressed (1000 kg/cm2) and sintered at 1050 ◦C for 2 h. These
pieces were ground with tungsten carbide mortar and sieved
to a size between 45 and 100 m.  Ceramic powders obtained
were used to test biodegradability in Tris–HCl. On the other
e c e r
h
s
C
S
p
u
P
a
a
M
b
s
4
w
u
i
(
a
f
b
T
p
M
E
m
c
B
T
h
c
o
f
Bioactivity of both materials was studied by SBF in vitro tests
for different periods of time (1–3 weeks). Disk-shaped sam-
ples were soaked into the SBF at pH 7.4 and 36.5 ◦C. An orbital
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  Ca2.81Mg0.19(PO4)2 (PDF: 70-0682)
Calcium magnesium phosphate.
  Ca3(PO4)2 (PDF: 9-0348)
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and, some of the obtained disks were used for in vitro SBF
tudies.
haracterization
tarting raw materials were characterized by determining the
article size distribution by laser diffraction, chemical analysis
sing Malvern Mastersizer S (UK) and X-ray ﬂuorescence using
hilips MagiX (Germany).
As described before, samples were ground to powder with
n average size below 100 m using a tungsten carbide mill
nd characterized by X-ray diffraction (XRD) using a Bruker
ultiload D8 diffractometer (Germany). Data were collected
etween 10◦ and 60◦ (2) in 0.05◦ steps, counting for 1 s per
tep and using CuK radiation. The X-ray tube was operated at
0 kV at 40 mA.  The Eva-version 6.0.0.1 Diffract plus software
as used to evaluate the diffraction patterns.
Speciﬁc area of the obtained powders was determined
sing Quantachrome Monosorb Surface Area Analyser MS-13.
Tris–HCl solutions after treatments were analyzed by
nductively coupled plasma atomic emission spectroscopy
ICP-AES) Iris Advantage of Thermo Jarrel Ash.
The morphology of the glass-ceramic and ceramic samples
nd the potential formation of hydroxyapatite layer on the sur-
ace of these biomaterials when immersed in SBF were studied
y two kinds of Scanning Electron Microscopes. First a Hitachi
M-1000 SEM was used as ﬁrst approximation. Selected sam-
les were observed using a Field Emission Scanning Electron
icroscope (FE-SEM), Hitachi S4700 (Japan), equipped with
nergy Dispersive X-ray Spectroscopy (EDS). The samples were
ounted in an adhesive carbon ﬁlm for its observation and Ag
oated by sputtering.
iodegradability  in  Tris–HCl
he speciﬁc surface area and particle size are variables that
ave a high incidence into the dissolution–precipitation pro-
ess, especially if the process kinetics is very slow. The amount
f sample contacted with the solution was calculated to use
or both powders the same Sa/Vs ratio, with Sa: sample surface
Table 1 – Some physical and chemical properties of the
raw materials used.
% Ca3(PO4)2 CaSiO3 3MgO·4SiO2
Particle size (Ø50% m) 5.7 3.2 7.6
Chemical
analysis (XRF) (%)
CaO 49.2 45.9 –
P2O5 42.8 – –
SiO2 – 50.4 60.6
MgO – – 31.0
Loss on
ignition
4.6 1.4 5.9
Table 2 – Speciﬁc surface area (SSA) of the glass-ceramic
and ceramic powders after milling.
G-TCP60 C-TCP60
SSA (m2/g) 0.36 2.85 á m i c a y v i d r i o 5 4 (2 0 1 5) 181–188 183
treated, Vs: volume of solution Tris–HCl (ml). For this study a
ratio Sa/Vs = 3 m2/dm3 was used.
35 mg  of C-TCP60 and 250 mg  of G-TCP60 were deposited in
100 ml  polyethylene tubes with conical bottom, and then were
added the buffer solution Tris–HCl pH 7.4 ± 0.02 and 36.5◦ C,
as proposed by Ducheyne et al. [10].
After 24 h, and 1, 2, 4 and 8 weeks of treatment, the solu-
tion was ﬁltered and the powder washed several times with
deionized water and then dried. The released Ca, Mg,  Si and P
ions to the medium were analyzed by ICP-AES.
Bioactivity  in  static  simulated  body  ﬂuid
The preparation of the SBF was carried out following the pro-
cedure reported in the ISO standard: 23317 [12], which is based
on that proposed by Kokubo and Takadama [9]. The samples of
the materials were placed in a plastic holder and then in a plas-
tic container. For this study a ratio of volume of liquid/sample
surface 0.1 cm3/mm2 was used.C-TCP60
B
  Ca2.81Mg 0.19(PO4)2 (PDF: 70-0682)
Calcium magnesium phosphate.
  CaSiO3 (PDF: 84-0655)
Wollastonite 2M.
  Mg2Si 2O6  (PDF: 86-0431)
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Fig. 1 – XRD patterns of the glass-ceramic (A) and the
ceramic (B) materials with main peaks of each phase
detected and labeled. These XRD patterns correspond
to both materials before the in vitro experiments.
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A–C)Fig. 2 – Hitachi TM-1000 SEM pictures of the glass-ceramic (
shaker incubator with an agitation rate of 80 rpm was used.
The evolution of the phases and the microstructural changes
of the surface of the samples with the time of exposure to the
solution were studied by SEM.
Results  and  discussion
The results of the characterization of the raw materials and of
the study materials are shown in Tables 1 and 2, respectively:
Glass-ceramic  and  ceramic  characterization  before
bioactivity  studies
Glass-ceramic (Fig. 1A) and ceramic (Fig. 1B) powders were
characterized by XRD. The results indicated that the obtained
XRD diffraction pattern of the glass-ceramic (Fig. 1A) pre-
sented a broad peak centered at 30 2-degrees. This signal
conﬁrmed the amorphous structure of this sample [11,13].
Also the presence of crystalline phases was observed, and the ceramic (D–F) materials before immersion in SBF.
speciﬁcally -tricalcium phosphate, with magnesium solid
solution, Ca2.81Mg0.19(PO4)2, and -tricalcium phosphate, -
Ca3(PO4)2. 70-0682 and 9-0348 powder diffraction ﬁles were
used respectively for its identiﬁcation (The International
Centre for Diffraction Data, ICDD. www.icdd.com). This
indicates that the glass is devitriﬁed during the cooling
step. This crystallization would inﬂuence on its bioactive
behavior.
XRD results obtained with the C-TCP60 powder are shown
in Fig. 1B. This poly-crystalline material had only crystalline
phases. The ceramic material contains -tricalcium phos-
phate, with magnesium solid solution, Ca2.81Mg0.19(PO4)2,
wollastonite 2 M, CaSiO3, and probably traces of enstatite,
Mg2Si2O6. 70-0682, 84-0655 and 86-0431 powder diffraction
ﬁles were used respectively for its identiﬁcation.
Fig. 2A–C shows different aspects of the fracture surface
of the glass-ceramic. The images show the typical texture of
a glass-ceramic material. The observed texture is produced
by the combination of the glassy phase and the devitriﬁed
crystalline phases detected by XRD (see Fig. 1A).
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Fig. 3 – Release of calcium (Ca), magnesium (Mg), phosphorous (P) and silicon (Si) ions in Tris–HCl experiments
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Fig. 2C–F shows the texture of the unpolished surface of
 sintered pressed-disk of the ceramic material. This kind
f observation was performed aiming to compare the sur-
ace of the samples before and after the SBF experiment.
he microstructure is made up of crystals with different mor-
hologies and a large size distribution of grains. There is some
orosity between the grains that are composed of several
hases of silicates and phosphates as detected by XRD (see
ig. 1B).
iodegradability  in  Tris–HCl
he result of the Tris–HCl experiment in vitro conducted using
owder particles of the samples is shown in Fig. 3. The amount
f extracted Ca, Si, P and Mg  ions from the materials were
easured up to 8 weeks of immersion in the solution. To com-
are the behavior of both materials the amount of each sample
dded to each polyethylene tube was measured and taken into
ccount to calculate the percentage of elements released into
he ﬁltered liquid.
From experimental data, it was found that both materi-
ls released gradually Ca throughout the test. A maximum
alue is not reached during the experiment. In both cases,
lass-ceramic and ceramic samples, the behavior is similar,
ecreasing the lixiviation rate with time. It looks like the
echanism is controlled by diffusion as is usually consid-
red. It is important to stand out that the amount of extracted
a from the glass-ceramic sample is more  than double the
mount of Ca extracted from the ceramic material. It is quite
emarkable that the amount of Ca leached from the glass-
eramic is around 15% from the total Ca of the sample. By usinga spherical model for the particles’ morphology it was esti-
mated that the Ca was completely removed from the surface
layer of the particles. The thickness of this layer was estimated
at 5% of the whole particle’s radius. In other words, that means
that the “penetration of attack” is around 5% in depth for the
cations.
In the case of Mg the behavior is quite similar. Only  the
quantities extracted are different, that is lower for both sam-
ples compared with each own Ca amount extracted. The
difference of release of Mg  is bigger between both materials
than in the case of Ca. Extrapolating from a spherical model of
particles, in this case the “penetration of attack” is around 3%
in depth for the glass-ceramic. It is noticeable that Mg  from the
silicate phases detected in the Ceramic material is less labile
than Ca.
When analyzing the evolution of the P release, both mate-
rials showed a maximum rate at around 24 h and from that
point gradually decreased. This was probably due to that
when the phosphorus is dissolved, in the presence of Ca
and Mg, it reaches solubility product value and then starts
the nucleation on the surface of the particles of powders. If
the medium is suitable, these phosphates provide the basis
for the hydroxyapatite formation over the material surface.
The excess of Ca and Mg induces the common ion effect,
so that the precipitation reaction between Ca, Mg  and P is
promoted on the surface as mentioned. The level of P in
the solution for the ceramic material is higher than in the
2+glass material. It is in agreement with the level of Ca and
Mg2+ cations in the solution and the solubility product. This
must be considered in order to explain the level of Ca and
Mg in the solution. That means that the level of Ca and Mg
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kev
B
urfaFig. 4 – FE-SEM Hitachi S4700 pictures of the glass-ceramic s
recorded from the coating layer (D).released is higher but part of them was precipitated to form
phosphates. In the case of Ca, it is coming not only from
the Tricalcium Phosphate but also from the silicate phase
present [14].
Fig. 5 – FE-SEM Hitachi S4700 pictures of the ceramicce after being soaked 21 days in SBF (A–C). EDS  spectraApparently the evolution of silicon released shows a dif-
ferent behavior in both samples. As it can be seen in Fig. 3
the amount of silicon released from both samples is grow-
ing up in the ﬁrst two weeks and from that point it remains
 surface after being soaked 21 days in SBF (A–D).
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onstant. It seems that the dissolution process is slowed by the
recipitation of the phosphates or silicates. The glass showed
 faster release rate. An apparent maximum appears after one
eek of experiment but further experimental work is needed
o understand this behavior.
The structure of the glassy phase within the glass-ceramic
s made out of a network in which P, Si, Ca and Mg atoms are
omogeneously distributed in the material [15]. This structure
llows P to have a continuous diffusion path to the sur-
ace. Additionally, the structural homogeneity of glass allowed
elease of Ca and Mg  ions from any point on the surface in
ontact with the solution of Tris–HCl [16].
On the other hand, the ceramic material is a polycrystalline
aterial whose phases are “heterogeneously” distributed. The
issolution of the phases occurs gradually and some grains do
ot come into contact with the solution, hence do not dissolve.
his is the reason why this material shows more  stable behav-
or than the glass-ceramic during this in vitro experiment.
The solubility order is: glassy phase > CaSiO3 > -
a3(PO4)2 > -Ca3(PO4)2 > Mg2Si2O6, bearing in mind the
esults of the present Tris–HCl test and bibliographic data
17,18].
ioactivity  in  SBF
EM micrographs of the glass-ceramic and ceramic surfaces
fter the immersion in SBF up to 21 days are shown in Fig. 4.
hanges can be noticed for all samples.
A layer covering the surface of the glass-ceramic sam-
le was observed after 21 days of soaking in SBF (Fig. 4A–C).
he visible cracks displayed by the layer in some images
re artifacts caused by the drying process of the specimen
n air after the test [8,19]. Even some spalling of the cover-
ng layer is observed at the top right corner of Fig. 4A. This
ayer was composed of crystals with plate-like morphology
Fig. 4B and C). This morphology is typical of apatite [8,19].
he SEM/EDS microanalysis performed showed that the newly
ormed apatite layer contained mainly Ca, P. Also, some Si
nd Mg  elements coming from the underneath sample were
etected in the EDS spectra (Fig. 4D).
Consistent with the results of the Tris–HCl solution, few
ggregates of apatite crystallites are formed on the surface of
he ceramic material after 21 days of soaking in SBF (Fig. 5A–D).
ome aggregates of crystals with the typical morphology of
patite are shown in Fig. 5B–D. Once again this material shows
ore stable behavior than the glass-ceramic during the in vitro
xperiments. In this case, the SEM/EDS microanalysis per-
ormed showed a high background noise of elements coming
rom the underneath sample and is not shown here.
onclusions
wo different Ca3(PO4)2 based biomaterials, a glass-ceramic
nd a ceramic, with the same chemical composition, have
een obtained. Both materials exposed to the SBF led to the formation of
apatite crystals. These crystals form a continuous layer onto
the surface of the glass-ceramic material after 21 days of á m i c a y v i d r i o 5 4 (2 0 1 5) 181–188 187
soaking while few crystals are formed onto the surface of
the glass-ceramic material.
- In all cases (SBF and Tris–HCl tests), higher reactivity has
been observed in glass-ceramic material.
- The “penetration of attack” for Mg and Ca cations in the
glass-ceramic material was estimated between ∼3 and 5%
in depth by using a spherical model for the particles’ mor-
phology. Nevertheless, at the same time there are some
precipitations of secondary phases because the content on
the different ions reaches solubility product values.
- Differences in the reactivity of the samples in acellular
solutions are due to differences in their mineralogical com-
position. The identiﬁed phases exhibit different solubility
in Tris–HCl and SBF tests. The solubility order is: glassy
phase > CaSiO3 > -Ca3(PO4)2 > -Ca3(PO4)2 > Mg2Si2O6.
- These differences give the opportunity to design composite
materials mixing glass and ceramic powders according to
their reactivity.
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